Heart, Lung and Circulation

Invasive Assessment of Microvascular Resistance in Hypertrophic Cardiomyopathy With Echocardiographic Correlates


      Hypertrophic cardiomyopathy (HCM) is often associated with ischaemia despite lack of focal epicardial coronary stenosis. Our aim was to assess invasive coronary microvascular circulation and correlate findings with echocardiography.


      We prospectively enrolled patients with HCM and controls who were referred for diagnostic coronary angiography. A pressure-temperature sensor coronary guidewire was used with intracoronary injections of room-temperature saline to measure mean coronary transit time during rest and hyperaemia induced with intravenous adenosine. The index of microvascular resistance (IMR) was calculated. Left ventricular mass was calculated during echocardiographic studies.


      Patients with HCM (n=12) and controls (n=7), had similar demographics. Left ventricular ejection fraction was higher in HCM (76.7%±11.0% vs 55.0%±15.9%, p=0.003). IMR was non-significantly higher in HCM (21.7±10.2 vs 15.3±4.8, p=0.16). Only patients with HCM had abnormal IMR (>25). Coronary flow reserve was non-significantly higher in HCM (2.7±1.6 vs 2.1±1.2, p=0.34). IMR correlated with left ventricular mass in hypertrophic cardiomyopathy subjects (Pearson r=0.68, p=0.02).


      Microvascular dysfunction as assessed by IMR may be abnormal in HCM and is correlated with left ventricular mass.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cao Y.
        • Zhang P.Y.
        Review of recent advances in the management of hypertrophic cardiomyopathy.
        Eur Rev Med Pharmacol Sci. 2017; 21: 5207-5210
        • Kuusisto J.
        • Sipola P.
        • Jääskeläinen P.
        • Naukkarinen A.
        Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
        Ann Med. 2016; 48: 496-508
        • Chan N.
        • Kataria V.
        • Delphin J.
        • Auerbach A.
        • Makaryus J.N.
        Marked multi-distribution myocardial ischemia in a patient with hypertrophic cardiomyopathy and no obstructive coronary artery disease.
        J Nucl Cardiol. 2019; : 1-3
        • Gutiérrez-Barrios A.
        • Camacho-Jurado F.
        • Díaz-Retamino E.
        • Gamaza-Chulián S.
        • Agarrado-Luna A.
        • Oneto-Otero J.
        • et al.
        Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistance.
        Cardiovasc Revasc Med. 2015; 16: 426-428
        • Fearon W.F.
        • Balsam L.B.
        • Farouque H.M.O.
        • Robbins R.C.
        • Fitzgerald P.J.
        • Yock P.G.
        • et al.
        Novel index for invasively assessing the coronary microcirculation.
        Circulation. 2003; 107: 3129-3132
        • Ng M.K.C.
        • Yeung A.C.
        • Fearon W.F.
        Invasive assessment of the coronary microcirculation.
        Circulation. 2006; 113: 2054-2061
        • Evans J.D.
        Straightforward statistics for the behavioral sciences.
        Brooks/Cole Pub. Co, Pacific Grove1996 (600-p)
        • Lee J.M.
        • Layland J.
        • Jung J.H.
        • Lee H.J.
        • Echavarria-Pinto M.
        • Watkins S.
        • et al.
        Integrated physiologic assessment of ischemic heart disease in real-world practice using index of microcirculatory resistance and fractional flow reserve: insights from the International Index of Microcirculatory Resistance Registry.
        Circ Cardiovasc Interv. 2015; 8: e002857
        • Melikian N.
        • Vercauteren S.
        • Fearon W.F.
        • Cuisset T.
        • MacCarthy P.A.
        • Davidavicius G.
        • et al.
        Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis.
        EuroIntervention. 2010; 5: 939-945
      1. Kofflard MJ, Michels M Fau - Krams R, Krams R Fau - Kliffen M, Kliffen M Fau - Geleijnse ML, Geleijnse Ml Fau - Ten Cate FJ, Ten Cate Fj Fau - Serruys PW, et al. Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics. (1568-5888 (Print)).

        • Knaapen P.
        • Germans T.
        • Camici P.G.
        • Rimoldi O.E.
        • ten Cate F.J.
        • ten Berg J.M.
        • et al.
        Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
        Am J Physiol Heart Circ Physiol. 2008; 294: H986-H993
        • Tesic M.
        • Djordjevic-Dikic A.
        • Beleslin B.
        • Trifunovic D.
        • Giga V.
        • Marinkovic J.
        • et al.
        Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis.
        J Am Soc Echocardiogr. 2013; 26: 775-782
        • Lin C.
        • Zhang P.
        • Xue Y.
        • Huang Y.
        • Ji K.
        Link of renal microcirculatory dysfunction to increased coronary microcirculatory resistance in hypertensive patients.
        Cardiol J. 2017; 24: 623-632
        • Gutiérrez-Barrios A.
        • Gamaza-Chulián S.
        • Agarrado-Luna A.
        • Ruiz-Fernández D.
        • Calle-Pérez G.
        • Marante-Fuertes E.
        • et al.
        Invasive assessment of coronary flow reserve impairment in severe aortic stenosis and ecochadiographic correlations.
        Int J Cardiol. 2017; 236: 370-374